PCOS and Reproductive Health Benefits GLP-1 receptor agonists are an emerging option for managing polycystic ovary syndrome (PCOS), which affects up to 10% of women of reproductive age
Medical Liens: If your health insurance or a government program paid for your medical treatment, they might have a right to be reimbursed from your settlement
Effect of supplementation of solid-state fermentation product of Bacillus subtilis HGcc-1 to high-fat diet on growth, hepatic lipid metabolism, epidermal mucus, gut and liver health and gut microbiota of zebrafish
Molecular insights into the early stage of glomerular injury in IgA nephropathy using single-cell RNA sequencing
conducted a 32-week clinical trial involving 84 adults with HIV and lipohypertrophy, a common condition where fat deposits form under the skin
It is a challenge to predict the individual response to GLP-1RAs through accurate medical treatment and optimize the treatment plan accordingly